Jaroslava Joniová

Dr. Jaroslava Joniová

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
JJJaroslava Joniová
Jaroslava Joniová
CKCyrus Kazemiraad
Cyrus Kazemiraad
EGEmmanuel Gerelli
Emmanuel Gerelli
Georges WagnieresGeorges Wagnieres
Georges Wagnieres

31 May 2024 in Life Sciences
Verified
Journal Article
Open access
JJJaroslava Joniová
Jaroslava Joniová
EGEmmanuel Gerelli
Emmanuel Gerelli
GWGeorges Wagnières
Georges Wagnières
Photobiomodulation (PBM) represents a promising and powerful approach for non-invasive therapeutic interventions. This emerging field of research has gained a considerable attention due to its potential for multiple disciplines, including medicine, neuroscience, and sports medicine. While PBM has shown the ability to stimulate various cellular processes in numerous medical applications, the fine-tuning of treatment parameters, such as wavelength, irradiance, treatment duration, and illumination geometry, remains an ongoing challenge. Furthermore, additional research is necessary to unveil the specific mechanisms of action and establish standardized protocols for diverse clinical applications. Given the widely accepted understanding that mitochondria play a pivotal role in the PBM mechanisms, our study delves into a multitude of PBM illumination parameters while assessing the PBM's effects on the basis of endpoints reflecting the mitochondrial metabolism of human cardiac myocytes (HCM), that are known for their high mitochondrial density. These endpoints include: i) the endogenous production of protoporphyrin IX (PpIX), ii) changes in mitochondrial potential monitored by Rhodamine 123 (Rhod 123), iii) changes in the HCM's oxygen consumption, iv) the fluorescence lifetime of Rhod 123 in mitochondria, and v) alterations of the mitochondrial morphology. The good correlation observed between these different methods to assess PBM effects underscores that monitoring the endogenous PpIX production offers interesting indirect insights into the mitochondrial metabolic activity. This conclusion is important since many approved therapeutics and cancer detection approaches are based on the use of PpIX. Finally, this correlation strongly suggests that the PBM effects mentioned above have a common "fundamental" mechanistic origin.

Verified
Journal Article
Open access
PDF file
JJJaroslava Joniová
Jaroslava Joniová
AGAurelien Gregor
Aurelien Gregor
MLMartine Lambelet
Martine Lambelet
SDSébastien Déglise
Sébastien Déglise
FAFlorent ALLAGNAT
Florent ALLAGNAT
Georges WagnieresGeorges Wagnieres
Georges Wagnieres
Photobiomodulation (PBM) therapy, a therapeutic approach utilizing low-level light, has garnered significant attention for its potential to modulate various biological processes. This study aimed at optimizing and investigating the effects of PBM on angiogenesis and mitochondrial metabolic activity. In vitro experiments using human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) were performed to assess PBM’s impacts on cell migration, proliferation, endogenous protoporphyrin IX production, mitochondrial membrane potential, Rhodamine 123 fluorescence lifetime, mitochondrial morphology, and oxygen consumption. Our findings demonstrated that the PBM approach significantly stimulates HUVECs and VSMCs, highlighting the importance of precise light dosimetry for optimal outcomes. Interestingly, our results indicate that in our conditions, the optimal radiometric and spectral parameters are similar for HUVECs and VSMCs for the different endpoints mentioned above. In conclusion, our study strongly suggests that PBM holds promise as a therapeutic intervention for conditions characterized by impaired angiogenesis, such as wound healing, ischemia, and cardiovascular disease. Further research is necessary to fully elucidate the underlying mechanisms and optimize the radiometric and spectral parameters for clinical applications.

1 December 2016 in Journal of Biomedical Optics
Verified
Journal Article
Closed access
PDF file
JJJaroslava Joniová
Jaroslava Joniová
EGEmmanuel Gerelli
Emmanuel Gerelli
MZMatthieu Zellweger
Matthieu Zellweger
Georges WagnieresGeorges Wagnieres
Georges Wagnieres
The availability of reproducible, convenient, and inexpensive model organisms able to generate predictable levels of endogenous porphyrins, including protoporphyrin IX (PpIX), is essential in photomedicine research. Saccharomyces cerevisiae produces endogenous PpIX and was used as a model organism for this study with the aim to maximize endogenous PpIX fluorescence intensity. It was found that PpIX fluorescence was significantly enhanced by administration of 5-aminolevulinic acid (ALA) and 2,2′-bipyridyl. Fluorescence intensity and spectroscopy of PpIX produced endogenously were measured in diluted yeast solutions under various conditions. The optimal protocol was: 5  μM ALA and 1 mM 2,2′-bipyridyl administered synchronously at 32°C. After 3 h, PpIX in yeast demonstrated similar steady-state and time-resolved spectroscopy as that of PpIX in DMSO. Moreover, under hypoxic conditions, the reciprocal lifetime of PpIX delayed fluorescence measured in real time was correlated to the partial pressure of oxygen (pO2) measured concomitantly with a commercially available pO2 probe. These data show that yeast can, in optimal conditions, reproducibly generate PpIX. This is of interest in various fields such as photodiagnosis, photodynamic therapy, and photobiomodulation. Use of this model organism focuses on essential mechanisms, without the complexity of a multicellular organism.

12 February 2020 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
JJJaroslava Joniová
Jaroslava Joniová
Georges WagnieresGeorges Wagnieres
Georges Wagnieres
Photodynamic therapy (PDT), a minimally invasive and clinically approved procedure, is used for the treatment of different types of (pre)cancers as well as certain forms of age-related macular degeneration.1,2 Three key elements are involved in PDT: a nontoxic photosensitizer (PS), light that excites the PS, and molecular oxygen. The PS, after excitation with light, can transfer some of its energy to the latter, which leads to the production of reactive oxygen species (ROS), in particular, singlet oxygen. These ROS induce cell/tissue damages, eventually resulting in cell death by apoptosis, necrosis, and/or autophagy.3 – 5

4 May 2022
Verified
Book Chapter
Closed access
PDF file
JJJaroslava Joniová
Jaroslava Joniová
GWGeorges Wagnières
Georges Wagnières